Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Efficacy and Tolerance, and Health Economic Study of a Single Administration of Pegfilgrastim in Lymphoma or Myeloma Patients Treated With Intensive Chemotherapy and Autologous Peripheral Stem Cell Transplantation

NCT00794261 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT00794261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00794261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Efficacy and Tolerance, and Health Economic Study of a Single Administration of Pegfilgrastim in Lymphoma or Myeloma Patients Treated With Intensive Chemotherapy and Autologous Peripheral Stem Cell Transplantation
Lead sponsor
Centre Leon Berard
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2008
Completion date
June 30, 2010
Enrollment
150 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, myeloma